One cupcake won't kill you', 'I'm going to get diabetes just looking at that', 'That person doesn't look like they have ...

Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...

Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

Abbott has launched Above the Bias, a global initiative to drive awareness about the health impact that common misconceptions and bias about diabetes can have on people living with ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

AbbottAs a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He's also taken on more than a few challe ...

The company's Q3 profir increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...

Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.